Researchers at Ohio State University have pinpointed a human gene product that helps to regulate wound healing and may control scarring in people recovering from severe injuries and damage to certain internal organs.
The protein, MG53, travels throughout the bloodstream and helps the body fix injuries to the skin, heart, lungs, kidneys and other organs without causing scars. It's a discovery that could help heal open wounds, decrease recovery time after surgery and reduce the spread of infections.
"A massive scar on your skin may look bad, but imagine you have a heart attack and get a scar on your heart-that could be lethal," says Jianjie Ma, a physiologist at Ohio State and co-author of the presentation.
All animals carry this gene, he said, and it's almost identical no matter which species. MG53 fixes the cell and tissue damage that occurs during everyday living. Even simple actions, like walking or typing, will cause injuries to the body. Usually this isn't a problem because MG53 can make repairs before there's any serious harm.
Ma and his team genetically engineered mice without the gene that makes MG53 to see what would happen without its healing capabilities. The experiments showed that the mice lacking MG53 had difficulty recovering from injury, because of their compromised repair capacity; their heart would not function well under stress conditions.
MG53 works in tandem with another protein called TGF Beta, a type of "cytokine" protein that also heals wounds, but the healing process happens so quickly that it causes scars. If you have more TGF Beta in your bloodstream than MG53, you scar easily.
Ma's goal is to develop a therapy that will inhibit TGF Beta and promote MG53. Medical professionals can use the therapy during procedures to promote quick, scarless healing. His next step is to identify a small compound that can do this and eventually test whether it has the desired effect in human trials.
Source: Biophysical Society
The Latest on CLABSIs and CAUTIs: Evidence-Based Approaches for Infection Prevention
February 27th 2025Health care–associated infections like CLABSIs and CAUTIs threaten patient safety. Learn evidence-based strategies, new technologies, and prevention protocols to reduce these infections and improve outcomes.
Hiding in Plain Sight: The Most Harmful and Costly Hospital-Acquired Infection
February 5th 2025Nonventilator hospital-acquired pneumonia (NV-HAP) is a deadly, overlooked infection impacting patient outcomes. With new diagnostic tools and prevention strategies, hospitals must prioritize oral hygiene to reduce risk.
The Hidden Dangers of Hospital Ventilation: Are We Spreading Viruses Further?
January 31st 2025New research reveals hospital ventilation and air purifiers may unintentionally spread viral particles, increasing infection risks. Infection preventionists must rethink airflow strategies to protect patients and staff.
Alcohol-Based Antiseptics Show Promise for Nasal Decolonization and SSI Prevention
January 23rd 2025A meta-analysis found alcohol-based antiseptics significantly reduce Staphylococcus aureus-related surgical site infections (SSIs), demonstrating efficacy comparable to mupirocin and iodophor, supporting their expanded use in infection prevention strategies.